Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutic targeting Activin receptor-like kinase ...
ALK7, the company’s investigational RNA interference therapeutic targeting Activin receptor-like kinase 7 being developed as a potential treatment for obesity. The results were presented in a poster ...
Vecima Networks Inc. announced today its "Turbocharged" DOCSIS 3.1 support for Entra® Remote MACPHY nodes with System Release 24.2.0. Vecima's Entra SC-1D2 and SC-2D Remote MACPHY Nodes enable ...
Beverly Hills MD®, the cutting-edge skincare line created by renowned plastic surgeons Dr. John Layke and Dr. Payman ...
Aro Granite Industries Ltd. key Products/Revenue Segments include Granite Slabs & Tiles for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...